本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 近日，金河生物科技股份有限公司（以下简称"公司"）收到内蒙古自治区 农牧厅核发的《内蒙古自治区农牧厅饲料添加剂产品批准文号审批表》，公司开 发的饲料添加剂红法夫酵母获得产品批准文号。 一、批准文号基本信息 产品名称：红法夫酵母 证券代码：002688 证券简称：金河生物 公告编号:2025-113 金河生物科技股份有限公司 关于获得饲料添加剂产品批准文号的公告 特此公告。 金河生物科技股份有限公司 董 事 会 2025 年 11 月 3 日 执行标准名称及编号：红法夫酵母，Q/JHSW 253-2025 批准文号：蒙饲添字（2025）090001 批准日期：2025年9月15日 二、对公司的影响 虾青素是红法夫酵母在发酵过程中的代谢产物。公司建有年产3,000吨虾青 素建设项目。公司取得该项饲料添加剂产品批准文号是公司持续重视研发创新、 加快合成生物学在产业应用和布局的结果。该项饲料添加剂产品批准文号的取得 将进一步丰富公司产品结构，对持续提升公司经营业绩和市场竞争力具有积极的 促进作用，预计不会对公 ...

Group 1 - The company received a notification from its controlling shareholder, Inner Mongolia Jinhai Holdings Co., Ltd., regarding the pledge and release of some shares [1] - As of the announcement date, the controlling shareholder and its concerted actors have pledged shares, with specific details provided in the announcement [1] - The controlling shareholder's credit status is good, with sufficient funds to repay, indicating that the risk associated with the pledged shares is manageable and does not pose a substantial impact on the company's operations or governance [1][2] Group 2 - The announcement includes documents such as the share pledge and release registration certificate and details of share freezes from China Securities Depository and Clearing Corporation Limited [2] - The board of directors of Jinhai Biotechnology Co., Ltd. issued the announcement on October 30, 2025 [3]

Investment Rating - The industry rating is "Recommended" [3] Core Insights - The pork price center has significantly risen, leading to a notable reduction in industry losses. The average price of live pigs has increased to 12.51 CNY/kg, a week-on-week rise of 7.20% [2][13] - The agricultural sector is expected to maintain a good development momentum, with grain production projected to be high this year, including summer grain production of 299.48 billion jin and early rice production increasing by 6.8 billion jin, a growth of 1.2% [1][12] - The industry is currently in a supply-demand tug-of-war, with large-scale pig farms adopting strategies to control supply and raise prices, while demand is expected to improve with the arrival of warmer weather and the pickling season [2][13] Summary by Sections Planting Industry Chain - The agricultural sector is implementing key policies to support rural economic development, with a focus on achieving food security and enhancing crop yields through biotechnology [1][12] - Major beneficiaries in the planting sector include Beidahuang and Suqian Agricultural Development, while in the seed industry, companies like Dabeinong and Longping High-Tech are highlighted for their competitive advantages [1][12] Pig Farming - The pig farming industry is still experiencing losses, but there has been a significant reduction in losses compared to the previous week, with self-breeding farms reporting an average loss of 89.33 CNY per head, down nearly 100 CNY [2][13] - The industry is expected to undergo a process of capacity reduction, with a focus on improving quality and efficiency, leading to the gradual elimination of outdated production capacity [2][13] - Recommended stocks in the pig farming sector include companies like DeKang Agriculture, Jingji Zhino, and Muyuan Foods [2][13] Key Agricultural Product Data Tracking - Corn: The average price is 2241.67 CNY/ton, with a week-on-week decrease of 0.66% [27][28] - Wheat: The average price is 2482.11 CNY/ton, with a week-on-week increase of 0.87% [30][32] - Soybeans: The average price is 3996.84 CNY/ton, with a week-on-week increase of 0.06% [41][44] - Cotton: The average price in Xinjiang is 14660 CNY/ton, with a week-on-week increase of 0.15% [46][50] Feed and Vitamin Prices - The average price of pig feed is 2.6 CNY/kg, with a week-on-week decrease of 0.38% [53][55] - The average price of Vitamin E is 50.30 CNY/kg, with a week-on-week increase of 14.58% [62][63]

Core Points - Jinhe Biological (002688) announced the resignation of Wang Yueqing, the director and deputy general manager, due to internal work adjustments [1] - Wang Yueqing also stepped down from her positions on the Board's Strategy Committee and the Compensation and Assessment Committee, but will continue to hold other roles within the company [1]

Core Points - Jinhe Biological announced the election of Wang Yueqing as the employee director of the sixth board of directors during the employee representative meeting held on October 31, 2025 [2] Summary by Category - **Company Announcement** - Jinhe Biological held an employee representative meeting on October 31, 2025, where Wang Yueqing was elected as the employee director [2]

证券代码：002688 证券简称：金河生物 公告编号：2025-112 二、职工代表董事选举情况 根据《公司法》《深圳证券交易所股票上市规则》《深圳证券交易所上市公 司自律监管指引第 1 号——主板上市公司规范运作》等法律法规、规范性文件以 及《公司章程》的相关规定，公司于 2025 年 10 月 31 日召开了职工代表大会， 经与会职工代表表决，选举王月清女士（简历详见附件）为第六届董事会职工董 1 事，任期自公司职工代表大会选举之日起至公司第六届董事会任期届满之日止。 王月清女士当选公司职工董事后，公司董事会中兼任公司高级管理人员以及由职 工代表担任的董事人数总计未超过公司董事总数的二分之一，符合相关法律法规 的规定。 三、补选董事会专门委员会委员情况 2025年10月31日，公司召开第六届董事会第三十四次会议审议通过了《关于 补选董事会专门委员会委员的议案》，同意补选王月清女士为公司第六届董事会 战略委员会委员、薪酬与考核委员会委员，任期自本次董事会会议审议通过之日 起至第六届董事会届满之日止。本次补选完成后，公司第六届董事会各专门委员 会委员如下： 金河生物科技股份有限公司 关于董事、副总经理辞任暨选 ...

華 聯 律 師 事 務 所 HuaL ianLa w F irm 中國北京市朝陽區亮马桥路32號高斓大厦10层 郵編: 100125 電話: 8610-84417811 傳真: 8610-84417306 電郵: hualian@hllf.cn 網址: www.hllf.cn 本所及经办律师依据《中华人民共和国公司法》（以下简称《公司法》）《中 华人民共和国证券法》（以下简称《证券法》）《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及本法律意 见书出具日以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤勉尽 责和诚实信用原则，进行了充分的核查验证，保证本法律意见所认定的事实真实、 准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导性陈述或 者重大遗漏，并承担相应法律责任。 一、本次股东大会的召集和召开程序 本次股东大会由公司董事会根据 2025 年 10 月 13 日召开的第六届董事会第 三十二次会议召集；公司董事会于 2025 年 10 月 15 日在《证券时报》《证券日 报》《上海证券报》《中国证券报》及巨潮资讯网（http://www.cni ...

证券代码：002688 证券简称：金河生物 公告编号：2025-110 金河生物科技股份有限公司 2025年第五次临时股东大会决议的公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 1、本次股东大会无否决提案的情形。 2、本次股东大会没有涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 金河生物科技股份有限公司（以下简称"公司"）2025 年第五次临时股东 大会通知于 2025 年 10 月 15 日在《上海证券报》、《证券时报》、《证券日报》 《中国证券报》及巨潮资讯网（www.cninfo.com.cn）以公告方式发出。 1、召开时间 （1）现场会议召开时间：2025 年 10 月 31 日下午 14:30 （2）网络投票时间：2025 年 10 月 31 日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 10 月 31 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证 券交易所互联网投票系统投票的具体时间为：2025 年 10 月 31 日上 ...

证券代码：002688 证券简称：金河生物 公告编号：2025-111 金河生物科技股份有限公司 第六届董事会第三十四次会议决议公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 金河生物科技股份有限公司（以下简称"公司"）第六届董事会第三十四次 会议于 2025 年 10 月 28 日以电子邮件方式发出通知，并于 2025 年 10 月 31 日以 现场方式召开，会议由董事长王东晓先生主持，应到董事 9 人，实到董事 9 人， 本次董事会出席会议董事人数符合法律法规，会议合法有效。会议召开符合《中 华人民共和国公司法》等法律、法规和《公司章程》的规定。与会董事以现场表 决的方式审议通过了以下议案： 以9票同意，0票反对，0票弃权审议通过了《关于补选董事会专门委员会委 员的议案》。 1 根据《公司法》《公司章程》及相关法律法规的规定，公司董事会补选王月 清女士为公司第六届董事会战略委员会委员、薪酬与考核委员会委员。任期自本 次董事会会议审议通过之日起至第六届董事会届满之日止。 具体内容详见《证券时报》《上海证券报》《证券日报》《中国证券报》及 巨 ...

Core Viewpoint - The demand for feed-grade chlortetracycline (金霉素) in China is expected to rise significantly due to increased livestock farming and new applications in ruminants, with an estimated usage of around 10,000 tons in 2024, reflecting a year-on-year increase of 25.0% [1][8]. Industry Overview - Feed-grade chlortetracycline, a widely used feed additive, is primarily utilized to promote animal growth and improve feed conversion rates while also preventing animal diseases [3]. - The production process involves multiple key steps, including raw material preparation, fermentation, filtration, drying, and quality inspection, ensuring high quality and stability of the final product [4]. Industry Chain - The industry chain consists of raw material supply (mainly corn, peanut meal, and yeast powder), production manufacturing, and application in livestock and aquaculture [5][6]. Current Industry Status - The production of feed-grade chlortetracycline in China began in 1986, but the "comprehensive ban on antibiotics" policy implemented in July 2020 has limited the use of many growth-promoting additives. However, chlortetracycline remains in use due to its clinical effectiveness and low drug residues [7][8]. Competitive Landscape - The market is dominated by a few key players, with 金河生物 (Jinhe Biology) holding a 51% market share, followed by 驻马店华中正大 (Zhumadian Huazhong Zhengda) at 26% and 浦城正大 (Pucheng Zhengda) at 19% [9]. - 金河生物 reported a revenue of 1.39 billion yuan in the first half of 2025, a year-on-year increase of 30.45%, with a net profit of 138 million yuan, up 51.52% [10]. Development Trends - The industry is facing stricter environmental regulations, necessitating increased investment in advanced technologies to reduce waste emissions [12]. - There is a trend towards optimizing product structures, with new formulations like sustained-release and composite products expected to replace traditional types [13]. - The penetration of Chinese feed-grade chlortetracycline in overseas markets is anticipated to increase, particularly in emerging markets such as Southeast Asia and Africa, driven by initiatives like the Belt and Road [14].